Breaking News
Sort by:
Top Post
Statement from Steve Barclay, Secretary of State for Health and Social Care
Health and Social Care Secretary Steve Barclay said: It is an honour to take up […]
Digital Revolution to Bust COVID Backlogs and Deliver More Tailored Care for Patients
People across the country will benefit from faster, more personalised healthcare, following a digital revolution […]
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and […]
Concentric by Ginkgo Crosses 10 Million Samples Tested and Expands Testing and Sequencing Capabilities to Detect Monkeypox and Other Pathogens, as Part of Scaling Its Global Biosecurity Infrastructure
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced plans to further […]
Moderna Announces Bivalent Booster mRNA -1273.214 Demonstrates Potent Neutralizing Antibody Response Against Omicron Subvariants Ba.4 and Ba.5
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Huma Joins Forces With Independent Healthcare Provider to Launch Virtual Ward Service for the NHS
Huma are partnering with Xyla Elective Care, a national provider of NHS England-funded elective services, […]
Moderna Announces Plan to Bring mRNA Innovation to the United Kingdom
Moderna, Inc . (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Therorna Completes Series A Financing to Accelerate Pipeline Development and Clinical Transformation of circRNA-based Platform
Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) […]
BIOTEM Implements New Industrial Unit Dedicated to Development and Production of Immunoassays
BIOTEM, a hybrid Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) focusing on high […]
EUROIMMUN Launches Two Assays for the Quantification of SARS-CoV-2 Antibodies
EUROIMMUN, a PerkinElmer company, today announced the launch of two CE marked assays – the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more